Ischemic preconditioning of skeletal muscle: Duration of late-phase protection

Annals of Plastic Surgery

Volumn 55, Issue 2, 2005, Pages 216-222

  Harralson, Thomas ^a   Grossi, Federico V ^a   Quan, Edwin E ^a   Tecimer, Taskin ^a   Perez Abadia, Gustavo ^a   Anderson, Gary ^a   Barker, John H ^a   Maldonado, Claudio ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Cardiomyoplasty; Contractile function; Ischemic preconditioning; Late phase protection; Necrosis; Rat; Skeletal muscle

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; HEART INFARCTION PREVENTION; INTERMETHOD COMPARISON; MALE; MUSCLE CONTRACTILITY; MUSCLE FLAP; MUSCLE FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; SURGICAL APPROACH; SURGICAL TECHNIQUE; TIME SERIES ANALYSIS; TISSUE NECROSIS;

ANIMALS; HUMANS; ISCHEMIC PRECONDITIONING; MALE; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NECROSIS; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS; TIME FACTORS;

EID: 22944458508     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sap.0000164578.85395.c7     Document Type: Article

References (57)

1. Morita K. [Dynamic cardiomyoplasty]. Nippon Geka Gakkai Zasshi. 2002;103:594-596.
2. El Oakley RM, Jarvis JC. Cardiomyoplasty: a critical review of experimental and clinical results. Circulation. 1994;90:2085-2090.
3. Hagege AA, Desnos M, Fernandez F, et al. Clinical study of the effects of latissimus dorsi muscle flap stimulation after cardiomyoplasty. Circulation. 1995;92:11210-11215.
4. Jondeau G, Dorent R, Bors V, et al. Dynamic cardiomyoplasty: effect of discontinuing latissimus dorsi muscle stimulation on left ventricular systolic and diastolic performance and exercise capacity. J Am Coll Cardiol. 1995;26:129-134.
5. Kratz JM, Johnson WS, Mukherjee R, et al. The relation between latissimus dorsi skeletal muscle structure and contractile function after cardiomyoplasty. J Thorac Cardiovasc Surg. 1994;107:868-878.
6. Lucas CM, Van der Veen FH, Cheriex EC, et al. Long-term follow-up (12 to 35 weeks) after dynamic cardiomyoplasty. J Am Coll Cardiol. 1993;22:758-767.
7. Magovern GJ Sr, Simpson KA. Clinical cardiomyoplasty: review of the ten-year United States experience. Ann Thorac Surg. 1996;61:413-419.
8. Capouya ER, Gerber RS, Drinkwater DC Jr, et al. Girdling effect of nonstimulated cardiomyoplasty on left ventricular function. Ann Thorac Surg. 1993;56:867-870.
9. Kass DA, Baughman KL, Pak PH, et al. Reverse remodeling from cardiomyoplasty in human heart failure: external constraint versus active assist. Circulation. 1995;91:2314-2318.
10. Nakajima H, Niinami H, Hooper TL, et al. Cardiomyoplasty: probable mechanism of effectiveness using the pressure-volume relationship. Ann Thorac Surg. 1994;57:407-415.
11. Patel HJ, Lankford EB, Polidori DJ, et al. Dynamic cardiomyoplasty: its chronic and acute effects on the failing heart. J Thorac Cardiovasc Surg. 1997;114:169-178.
12. Anderson WA, Ianuzzo CD, Klabunde RE. Cardiomyoplasty: studies on goat latissimus dorsi blood flow and muscle damage following surgical dissection and chronic electrical stimulation. J Card Surg. 1996;11:237-246.
13. El Oakley RM, Jarvis JC, Barman D, et al. Factors affecting the integrity of latissimus dorsi muscle grafts: implications for cardiac assistance from skeletal muscle. J Heart Lung Transplant. 1995;14:359-365.
14. Ali AT, Santamore WP, Chiang BY, et al. Vascular delay of the latissimus dorsi provides an early hemodynamic benefit in dynamic cardiomyoplasty. Ann Thorac Surg. 1999;67:1304-1311.
15. Tang AT, Jarvis JC, Hooper TL, et al. Cardiomyoplasty: the benefits of electrical prestimulation of the latissimus dorsi muscle in situ. Ann Thorac Surg. 1999;68:46-51.
16. Carroll SM, Carroll CM, Stremel RW, et al. Vascular delay of the latissimus dorsi muscle: an essential component of cardiomyoplasty. Ann Thorac Surg. 1997;63:1034-1040.
17. Chiang BB, Ali A, Kashem A, et al. Two step cardiomyoplasty with vascular delay: effect of stimulation of latissimus dorsi muscle on diastolic function. ASAIO J. 1999;45:350-355.
18. Carroll CM, Carroll SM, Overgoor ML, et al. Acute ischemic preconditioning of skeletal muscle prior to flap elevation augments muscle-flap survival. Plast Reconstr Surg. 1997;100:58-65.
19. Pang CY, Yang RZ, Zhong A, et al. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res. 1995;29:782-788.
20. Quan EE, Ramirez S, Tecimer T, et al. Late-phase ischemic preconditioning in skeletal muscle: is the phenomenon protective? Microsurgery. 2004;24:151-156.
21. Maldonado C, Stadelmann WK., Ramirez S, et al. Preconditioning of latissimus dorsi muscle flaps with monophosphoryl lipid a. Plast Reconstr Surg. 2003;111:267-274.
22. Morris SD, Yellon DM. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. J Am Coll Cordial. 1997;29:1599-1606.
23. Pang CY, Forrest CR. Acute pharmacologic preconditioning as a new concept and alternative approach for prevention of skeletal muscle ischemic necrosis. Biochem Pharmacol. 1995;49:1023-1034.
24. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72:1293-1299.
25. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-1136.
26. Labbe R, Lindsay T, Gatley R, et al. Quantitation of postischemic skeletal muscle necrosis: histochemical and radioisotope techniques. J Surg Res. 1988;44:45-53.
27. Kitagawa K, Matsumoto M, Tagaya M, et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 1990;528:21-24.
28. Marber M, Walker D, Yellon D. Ischaemic preconditioning. BMJ. 1994;3081-2.
29. Jaberansari MT, Baxter GF, Muller CA, et al. Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium. J Am Coll Cardiol. 2001;37:1996-2001.
30. Yamashita N, Hoshida S, Taniguchi N, et al. A "second window of protection" occurs 24 h after ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 1998;30:1181-1189.
31. Bolli R, Bhatti ZA, Tang XL, et al. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res. 1997;81:42-52.
32. Ferencz A, Szanto Z, Kalmar-Nagy K, et al. Mitigation of oxidative injury by classic and delayed ischemic preconditioning prior to small bowel autotransplantation. Transplant Proc. 2004;36:286-288.
33. Maldonado C, Harralson MS, Quan EE, et al. Time course of the late phase of ischemic preconditioning in skeletal muscle. Presented at the Annual Meeting, American Society for Reconstructive Microsurgery, San Diego, CA, January 13, 2001.
34. Wang WZ, Tsai TM, Anderson GL. Late-preconditioning protection is evident in the microcirculation of denervated skeletal muscle. J Orthop Res. 1999;17:571-577.
35. Carroll SM, Heilman SJ, Stremel RW, et al. Vascular delay improves latissimus dorsi muscle perfusion and muscle function for use in cardiomyoplasty. Plast Reconstr Surg. 1997;99:1329-1337.
36. Colburn MD, Quinones-Baldrich WJ, Gelabert HA, et al. Standardization of skeletal muscle ischemic injury. J Surg Res. 1992;52:309-313.
37. Baxter GF, Goma FM, Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res Cardiol. 1997;92:159-167.
38. Baxter GF, Ferdinandy P. Delayed preconditioning of myocardium: current perspectives. Basic Res Cardiol. 2001;96:329-344.
39. Tang XL, Qiu Y, Park SW, et al. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res. 1996;79:424-434.
40. Bolli R. The late phase of preconditioning. Circ Res. 2000;87:972-983.
41. Takano H, Tang XL, Bolli R. Differential role of K(ATP) channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol Heart Circ Physiol. 2000;279:H2350-H2359.
42. Gross ER, Peart JN, Hsu AK, et al. K(ATP) opener-induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial K(ATP) channels, free radicals and MEK1/2. J Mol Cell Cardiol. 2003;35:985-992.
43. Patel HH, Hsu AK, Peart JN, et al. Sarcolemmal K(ATP) channel triggers opioid-induced delayed cardioprotection in the rat. Circ Res. 2002;91:186-188.
44. Baxter GF. Role of adenosine in delayed preconditioning of myocardium. Cardiovasc Res. 2002;55:483-494.
45. Maldonado C, Qiu Y, Tang XL, et al. Role of adenosine receptors in late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol. 1997;273:H1324-H1332.
46. Carvalho AJ, Hollett P, McKee NH. Recovery of synergistic skeletal muscle function following ischemia. J Surg Res. 1995;59:527-533.
47. Jacobson MD, Pedowitz RA, Oyama BK, et al. Muscle functional deficits after tourniquet ischemia. Am J Sports Med. 1994;22:372-377.
48. Labbe R, Lindsay T, Walker PM. The extent and distribution of skeletal muscle necrosis after graded periods of complete ischemia. J Vasc Surg. 1987;6:152-157.
49. Patterson S, Klenerman L. The effect of pneumatic tourniquets on the ultrastructure of skeletal muscle. J Bone Joint Surg Br. 1979;61-B:178-183.
50. Pedowitz RA, Friden J, Thornell LE. Skeletal muscle injury induced by a pneumatic tourniquet: an enzyme and immunohistochemical study in rabbits. J Surg Res. 1992;52:243-250.
51. Wang WZ, Anderson G, Firrell JC. Arteriole constriction following ischemia in denervated skeletal muscle. J Reconstr Microsurg. 1995;11:99-106.
52. Barren DJ, Etherington PJ, Winlove CP, et al. Combination of preconditioning and delayed flap elevation: evidence for improved perfusion and oxygenation of the latissimus dorsi muscle for cardiomyoplasty. Ann Thorac Surg. 2001;71:852-861.
53. Kashem A, Santamore WP, Chiang B, et al. Vascular delay and intermittent stimulation: keys to successful latissimus dorsi muscle stimulation. Ann Thorac Surg. 2001;71:1866-1873.
54. Ebrahim Z, Yellon DM, Baxter GF. Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanism. Am J Physiol Heart Circ Physiol. 2001;281:H1458-H1464.
55. Leesar MA, Stoddard M, Ahmed M, et al. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 1997;95:2500-2507.
56. Tsuchida A, Liu Y, Liu GS, et al. Alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res. 1994;75:576-585.
57. Kloner RA, Speakman MT, Przyklenk K. Ischemic preconditioning: a plea for rationally targeted clinical trials. Cardiovasc Res. 2002;55:526-533.